Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
79 Results Found
AHA, others urge HRSA to extend comment deadline on 340B rebate program
The AHA, joined by several other national groups representing 340B hospitals, Feb. 19 urged the Health Resources and Services Administration to extend the timeline for stakeholders to submit comments to the agency’s recent request for information on a new 340B rebate model program.
Appeals court upholds Minnesota’s 340B law in PhRMA lawsuit
The Minnesota Court of Appeals Feb. 17 affirmed a lower court decision in ruling that the state’s 340B contract pharmacy law is not preempted by federal law.
HHS releases RFI on new 340B rebate model
The Department of Health and Human Services Feb. 13 issued a request for information on a new 340B rebate model program.
House subcommittee hearing discusses impacts of drug pricing on health care costs
The House Energy and Commerce Subcommittee on Health today hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain.”
Appeals court upholds Louisiana 340B contract pharmacy law
The 5th U.S. Circuit Court of Appeals Feb. 9 affirmed a district court ruling upholding Louisiana’s 340B contract pharmacy law.
HHS says it will scrap current 340B Rebate Model Program
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart the administrative process for such a program.
AHA blog: 340B is a solution, not a threat to health care affordability
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and bipartisan health care challenges.
AHA urges HRSA to stop Eli Lilly’s 340B claims-data submission policy from going into effect
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect on Feb. 1, including by “assessing civil monetary penalties for intentionally overcharging 340B hospitals.”
Government drops appeal of preliminary injunction order in AHA 340B lawsuit on rebate model program
The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate Model Pilot Program.
1st Circuit denies stay, upholds district court’s halt of 340B rebate program
The 1st U.S. Circuit Court of Appeals Jan. 7 denied the government’s motion for a stay in a lawsuit filed by the AHA, the Maine Hospital Association and four safety-net health systems challenging the Department of Health and Human Services’ 340B Rebate Model Pilot Program. This means that the program remains on hold.